Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility
Jewel Imani(Brigham and Women's Hospital), Souheil El‐Chemaly(AVEO Oncology (United States)), Anthony M. Lamattina(Harvard University), Dong-Dong Ma(Brigham and Women's Hospital), Dawn Maynard(National Human Genome Research Institute), Iván O. Rosas(Brigham and Women's Hospital), Bernadette R. Gochuico(National Human Genome Research Institute), Shikshya Shrestha(Brigham and Women's Hospital), May Christine V. Malicdan(National Institutes of Health), Lauren Testa(National Human Genome Research Institute), Steven P. Bodine(National Human Genome Research Institute), Mark A. Perrella(Brigham and Women's Hospital), Raman Sood(National Institutes of Health), Benjamin Stump(Brigham and Women's Hospital), Arinze Nwokeji(Brigham and Women's Hospital), Kevin Bishop(National Human Genome Research Institute), Robert I. Handin(Brigham and Women's Hospital), Lisa R. Young(Children's Hospital of Philadelphia)
Cited by 6
Related Papers
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710